vs
Side-by-side financial comparison of GILAT SATELLITE NETWORKS LTD (GILT) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $152.7M, roughly 1.4× GILAT SATELLITE NETWORKS LTD). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 4.1%, a 53.3% gap on every dollar of revenue.
Gilat Satellite Networks Ltd. is an Israeli public company. It provides satellite-based broadband communications technology, its main expertise being the development, manufacture, and marketing of ground-based satellite systems for global communication via satellites.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
GILT vs IDYA — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $152.7M | $207.8M |
| Net Profit | $6.3M | $119.2M |
| Gross Margin | 35.8% | — |
| Operating Margin | 5.4% | 52.2% |
| Net Margin | 4.1% | 57.4% |
| Revenue YoY | — | — |
| Net Profit YoY | — | 330.1% |
| EPS (diluted) | $57016808.00 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $207.8M | ||
| Q2 25 | $152.7M | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | $126.6M | $0 | ||
| Q1 24 | — | $0 | ||
| Q2 23 | $106.9M | — | ||
| Q3 22 | — | $29.7M | ||
| Q2 22 | $98.2M | — |
| Q3 25 | — | $119.2M | ||
| Q2 25 | $6.3M | — | ||
| Q3 24 | — | $-51.8M | ||
| Q2 24 | $9.9M | $-52.8M | ||
| Q1 24 | — | $-39.6M | ||
| Q2 23 | $-2.0M | — | ||
| Q3 22 | — | $1.6M | ||
| Q2 22 | $-5.2M | — |
| Q3 25 | — | — | ||
| Q2 25 | 35.8% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 39.7% | — | ||
| Q1 24 | — | — | ||
| Q2 23 | 33.8% | — | ||
| Q3 22 | — | — | ||
| Q2 22 | 29.6% | — |
| Q3 25 | — | 52.2% | ||
| Q2 25 | 5.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 9.8% | — | ||
| Q1 24 | — | — | ||
| Q2 23 | 0.4% | — | ||
| Q3 22 | — | 2.2% | ||
| Q2 22 | -4.0% | — |
| Q3 25 | — | 57.4% | ||
| Q2 25 | 4.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 7.8% | — | ||
| Q1 24 | — | — | ||
| Q2 23 | -1.9% | — | ||
| Q3 22 | — | 5.4% | ||
| Q2 22 | -5.3% | — |
| Q3 25 | — | $1.33 | ||
| Q2 25 | $57016808.00 | — | ||
| Q3 24 | — | $-0.60 | ||
| Q2 24 | $56622204.00 | $-0.68 | ||
| Q1 24 | — | $-0.53 | ||
| Q2 23 | — | — | ||
| Q3 22 | — | $0.04 | ||
| Q2 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $64.9M | $786.9M |
| Total DebtLower is stronger | $56.5M | — |
| Stockholders' EquityBook value | $315.8M | $1.1B |
| Total Assets | $575.9M | $1.2B |
| Debt / EquityLower = less leverage | 0.18× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $786.9M | ||
| Q2 25 | $64.9M | — | ||
| Q3 24 | — | $920.0M | ||
| Q2 24 | $93.7M | $701.7M | ||
| Q1 24 | — | $698.8M | ||
| Q2 23 | $87.4M | — | ||
| Q3 22 | — | $386.2M | ||
| Q2 22 | $70.1M | — |
| Q3 25 | — | — | ||
| Q2 25 | $56.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $2.0M | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | — | — |
| Q3 25 | — | $1.1B | ||
| Q2 25 | $315.8M | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $282.8M | $931.7M | ||
| Q1 24 | — | $935.3M | ||
| Q2 23 | $255.0M | — | ||
| Q3 22 | — | $368.8M | ||
| Q2 22 | $245.7M | — |
| Q3 25 | — | $1.2B | ||
| Q2 25 | $575.9M | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $416.9M | $973.7M | ||
| Q1 24 | — | $961.5M | ||
| Q2 23 | $371.6M | — | ||
| Q3 22 | — | $410.9M | ||
| Q2 22 | $376.0M | — |
| Q3 25 | — | — | ||
| Q2 25 | 0.18× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $-49.2M | ||
| Q2 24 | $8.2M | $-32.9M | ||
| Q1 24 | — | $-43.8M | ||
| Q2 23 | — | — | ||
| Q3 22 | — | $-24.2M | ||
| Q2 22 | — | — |
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | $1.7M | $-33.9M | ||
| Q1 24 | — | $-45.1M | ||
| Q2 23 | — | — | ||
| Q3 22 | — | $-25.3M | ||
| Q2 22 | — | — |
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | -85.1% | ||
| Q2 22 | — | — |
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.2% | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | 3.7% | ||
| Q2 22 | — | — |
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | -14.96× | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
